Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis

Journal of Experimental Medicine

Volumn 197, Issue 9, 2003, Pages 1073-1081

  Bettelli, Estelle ^a   Pagany, Maria ^b   Weiner, Howard L ^a   Linington, Christopher ^b,c   Sobel, Raymond A ^d,e   Kuchroo, Vijay K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity of CNS; Disease model; Experimental autoimmune encephalomyelitis; MOG; Multiple sclerosis

Indexed keywords

AUTOANTIGEN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; T LYMPHOCYTE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE OPTIC NEURITIS; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOCOMPETENT CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OPTIC NERVE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; SENSITIZATION; SPINAL CORD; T LYMPHOCYTE; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; AUTOIMMUNE DISEASES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MYELIN-ASSOCIATED GLYCOPROTEIN; OPTIC NEURITIS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 0038523790     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021603     Document Type: Article

References (36)

1. Lassmann, H. 1998. Pathology of multiple sclerosis. In McAlpine's Multiple Sclerosis. A. Compston, G. Ebers, H. Lassmann, I. McDonald, B. Matthews, and H. Wekerle, editors. Churchill Livingstone, Hong Kong. 323-358.
2. Ghezzi, A., V. Martinelli, V. Torri, M. Zaffaroni, M. Rodegher, G. Comi, A. Zibetti, and N. Canal. 1999. Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J. Neurol. 246:770-775.
3. Soderstrom, M. 2001. Optic neuritis and multiple sclerosis. Acta Ophthalmol. Scand. 79:223-227.
4. Zamvil, S.S., D.J. Mitchell, A.C. Moore, K. Kitamura, L. Steinman, and J.B. Rothbard. 1986. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature. 324:258-260.
5. Tuohy, V.K., Z. Lu, R.A. Sobel, R.A. Laursen, and M.B. Lees. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142: 1523-1527.
6. Greer, J.M., V.K. Kuchroo, R.A. Sobel, and M.B. Lees. 1992. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J. Immunol. 149:783-788.
7. Greer, J.M., R.A. Sobel, A. Sette, S. Southwood, M.B. Lees, and V.K. Kuchroo. 1996. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J. Immunol. 156:371-379.
8. Mendel, I., N. Kerlero de Rosbo, and A. Ben-Nun. 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25:1951-1959.
9. Linington, C., T. Berger, L. Perry, S. Weerth, D. Hinze-Selch, Y. Zhang, H.C. Lu, H. Lassmann, and H. Wekerle. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23: 1364-1372.
10. Amor, S., N. Groome, C. Linington, M.M. Morris, K. Dornmair, M.V. Gardinier, J.M. Matthieu, and D. Baker. 1994. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153:4349-4356.
11. Kerlero de Rosbo, N., I. Mendel, and A. Ben-Nun. 1995. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur. J. Immunol. 25:985-993.
12. Genain, C.P., and S.L. Hauser. 1996. Allergic encephalomyelitis in common marmosets: pathogenesis of a multiple sclerosis-like lesion. Methods. 10:420-434.
13. Adelmann, M., J. Wood, I. Benzel, P. Fiori, H. Lassmann, J.M. Matthieu, M.V. Gardinier, K. Dornmair, and C. Linington. 1995. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J. Neuroimmunol. 63:17-27.
14. Kerlero de Rosbo, N., R. Milo, M.B. Lees, D. Burger, C.C. Bernard, and A. Ben-Nun. 1993. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92:2602-2608.
15. Sun, J., H. Link, T. Olsson, B.G. Xiao, G. Andersson, H.P. Ekre, C. Linington, and P. Diener. 1991. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146:1490-1495.
16. Berger, T., S. Weerth, K. Kojima, C. Linington, H. Wekerle, and H. Lassmann. 1997. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab. Invest. 76:355-364.
17. Raine, C.S., U. Traugott, R.B. Nussenblatt, and S.H. Stone. 1980. Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis. Lab. Invest. 42:327-335.
18. Hayreh, S.S., R.M. Massanari, T. Yamada, and S.M. Hayreh. 1981. Experimental allergic encephalomyelitis. I. Optic nerve and central nervous system manifestations. Invest. Ophthalmol. Vis. Sci. 21:256-269.
19. Hayreh, S.S. 1981. Experimental allergic encephalomyelitis. II. Retinal and other ocular manifestations. Invest. Ophthalmol. Vis. Sci. 21:270-281.
20. O'Neill, J.K., D. Baker, M.M. Morris, S.E. Gschmeissner, H.G. Jenkins, A.M. Butt, S.L. Kirvell, and S. Amor. 1998. Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: demyelination and fast axonal transport changes in disease. J. Neuroimmunol. 82:210-218.
21. Hu, P., J. Pollard, N. Hunt, J. Taylor, and T. Chan-Ling. 1998. Microvascular and cellular responses in the optic nerve of rats with acute experimental allergic encephalomyelitis (EAE). Brain Pathol. 8:475-486.
22. Lafaille, J.J., K. Nagashima, M. Katsuki, and S. Tonegawa. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell. 78:399-408.
23. Goverman, J., A. Woods, L. Larson, L.P. Weiner, L. Hood, and D.M. Zaller. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell. 72:551-560.
24. Waldner, H., M.J. Whitters, R.A. Sobel, M. Collins, and V.K. Kuchroo. 2000. Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. Proc. Natl. Acad. Sci. USA. 97:3412-3417.
25. Madsen, L.S., E.C. Andersson, L. Jansson, M. Krogsgaard, C.B. Andersen, J. Engberg, J.L. Strominger, A. Svejgaard, J.P. Hjorth, R. Holmdahl, et al. 1999. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat. Genet. 23:343-347.
26. Kouskoff, V., K. Signorelli, C. Benoist, and D. Mathis. 1995. Cassette vectors directing expression of T cell receptor genes in transgenic mice. J. Immunol. Methods. 180:273-280.
27. Linington, C., M. Webb, and P.L. Woodhams. 1984. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J. Neuroimmunol. 6:387-396.
28. Gunn, C.A., M.K. Richards, and C. Linington. 1990. The immune response to myelin proteolipid protein in the Lewis rat: identification of the immunodominant B cell epitope. J. Neuroimmunol. 27:155-162.
29. Mor, F., G.L. Boccaccio, and T. Unger. 1998. Expression of autoimmune disease-related antigens by cells of the immune system. J. Neurosci. Res. 54:254-262.
30. Derbinski, J., A. Schulte, B. Kyewski, and L. Klein. 2001. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2:1032-1039.
31. Weissert, R., K.L. de Graaf, M.K. Storch, S. Barth, C. Linington, H. Lassmann, and T. Olsson. 2001. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 166:7588-7599.
32. Soderstrom, M., J. Ya-Ping, J. Hillert, and H. Link. 1998. Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology. 50:708-714.
33. Storch, M.K., A. Stefferl, U. Brehm, R. Weissert, E. Wallstrom, M. Kerschensteiner, T. Olsson, C. Linington, and H. Lassmann. 1998. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8:681-694.
34. Sobel, R.A. 2000. Genetic and epigenetic influence on EAE phenotypes induced with different encephalitogenic peptides. J. Neuroimmunol. 108:45-52.
35. Muller, D.M., M.P. Pender, and J.M. Greer. 2000. A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction. Acta Neuropathol. (Berl.). 100:174-182.
36. Vanderlugt, C.L., and S.D. Miller. 2002. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2:85-95.